Once-Daily Administration of Budesonide Turbuhaler® was as Effective as Twice-Daily Treatment in Patients with Mild to Moderate Persistent Asthma

REFERENCES

• Laitinen L.A., Laitinen A., Haahtela T. Airway Mucosal Inflammation Even in Patients with Newly Diagnosed Asthma. Am. Rev. Respir. Dis. 1993; 147(3)697–704
   PubMedGoogle Scholar
• National Asthma Education and Prevention Program. Expert Panel Report II, Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97-4051. National Heart, Lung, and Blood Institute, National Institutes of Health: Bethesda, MD, 1997
   Google Scholar
• NHLBI/WHO Workshop Report. Global Strategy for Asthma Management and Prevention. NIH Publication No. 95-3659. National Heart, Lung, and Blood Institute, National Institutes of Health: Bethesda, MD, 1995
   Google Scholar
• Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Selroos O., Sovijärvi A., Stenius-Aarniala B., Svahn T., Tammivaara R., Laitinen L.A. Effect of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild Asthma. N. Engl. J. Med. 1994; 331(11)700–705
   PubMed Web of Science ®Google Scholar
• Selroos O., Backman R., Forsén K.O., Löfroos A.B., Niemistö M., Nyberg P., Nyholm J.E., Pietinalho A., Riska H. The Effect of Inhaled Corticosteroids in Asthma is Related to the Duration of Pretreatment Symptoms. Am. J. Respir. Crit. Care Med. 1994; 149(suppl: 4 part 2)A211
   Google Scholar
• Agertoft L., Pedersen S. Effects of Long-Term Treatment with an Inhaled Corticosteroid on Growth and Pulmonary Function in Asthmatic Children. Respir. Med. 1994; 88(5)373–381
   PubMed Web of Science ®Google Scholar
• Campbell L.M. Once-Daily Inhaled Corticosteroids in Mild to Moderate Asthma: Improving Acceptance of Treatment. Drugs 1999; 58(S4)25–33
   PubMedGoogle Scholar
• Jones A.H., Langdon C.G., Lee P.S., Lingham S.A., Nankani J.P., Follows R.M.A., Tollemar U., Richardson P.D. Pulmicort® Turbohaler® Once Daily as Initial Prophylactic Therapy for Asthma. Respir. Med. 1994; 88(4)293–299
   PubMed Web of Science ®Google Scholar
• Herjavecz I., Blomqvist P., Serrano A. Efficacy of Once- and Twice-Daily Administration of Budesonide via Turbuhaler® as Initial Therapy in Patients with Persistent Asthma. Respir. Med. 1999; 93(4)230–235
   PubMed Web of Science ®Google Scholar
• Stiksa G., Glennow C. A Clinical Comparison Between Budesonide Given Once and Twice Daily and Becotide Four Times Daily. Ann. Allergy 1985; 55(1)49–51
   PubMedGoogle Scholar
• Campbell L.M., Bodalia B., Gogbashian C.A., Gunn S.D., Humphreys P.J., Powell J.P. Once-Daily Budesonide: 400 µg Once Daily is as Effective as 200 µg Twice Daily in Controlling Childhood Asthma. Int. J. Clin. Pract. 1998; 52: 213–219
   PubMed Web of Science ®Google Scholar
• McFadden E.R., Thomas T.B., Edwards T.B., Kemp J.P., Metzger W.J., Nelson H.S., Storms W.W., Neidl M.J. Administration of Budesonide Once Daily by Means of Turbuhaler to Subjects with Stable Asthma. J. Allergy Clin. Immunol. 1999; 104(1)46–52
   PubMed Web of Science ®Google Scholar
• McCarthy T.P. The Use of a Once Daily Inhaled Glucocorticosteroid (Budesonide) in the Management of Childhood Asthma. Br. J. Clin. Res. 1993; 4: 55–61
   Google Scholar
• Boulet L.P., Cowie R.L., Negro R.D., Brett W., Gold M., Marques A., Thorburn W.S., Stepner N.M., Robson R. Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma. Can. Respir. J. 2000; 7(3)239–247
   PubMedGoogle Scholar
• Pincus D.J., Szelfler S.J., Ackerson L.M., Martin R.J. Chronotherapy of Asthma with Inhaled Steroids: The Effect of Dosage Timing on Drug Efficacy. J. Allergy Clin. Immunol. 1995; 95(6)1172–1178
   PubMed Web of Science ®Google Scholar
• Pincus D.J., Humeston T.R., Martin R.J. Further Studies on the Chronotherapy of Asthma with Inhaled Steroids: The Effect of Dosage Timing on Drug Efficacy. J. Allergy Clin. Immunol. 1997; 100(1)771–774
   PubMedGoogle Scholar
• American Thoracic Society. Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma. Am. Rev. Respir. Dis. 1987; 136: 225–244
   PubMed Web of Science ®Google Scholar
• Quanjer P.H. Standardized Lung Function Testing. Bull. Eur. Physiopathol. Respir. 1983; 19(suppl 5)1–95
   PubMedGoogle Scholar
• Venables T.L., Addlestone M.B., Smithers A.J., Blagden M.D., Weston D., Gooding T., Carr E.P., Follows R.M.A. A Comparison of the Efficacy and Patient Acceptability of Once Daily Budesonide via Turbohaler and Twice Daily Fluticasone Propionate via Disc-Inhaler at an Equal Daily Dose of 400 µg in Adult Asthmatics. Br. J. Clin. Res. 1996; 7: 15–32
   Google Scholar
• Chisholm S., Knuistingh N.A., Petri H. Once Daily Budesonide 200 mcg Is as Effective as Twice Daily 100 mcg in the Treatment of Mild Asthma. Am. J. Respir. Crit. Care Med. 1996; 153(suppl: 4 part 2)A343
   PubMedGoogle Scholar
• Möller C., Strömberg L., Oldaeus G., Arweström E., Kjellman M. Efficacy of Once-Daily Versus Twice-Daily Administration of Budesonide by Turbuhaler® in Children with Stable Asthma. Pediatr. Pulmonol. 1999; 28(5)337–343
   PubMed Web of Science ®Google Scholar
• Jonasson G., Edvardsen E., Carlsen K.-H. Clinical Efficacy of Low Dose Inhaled Budesonide in Children with Mild Asthma not Previously Treated with Steroids. Eur. Respir. J. 1997; 10(suppl 25)221s
   Google Scholar
• Toogood J.H., Baskerville J.C., Jennings B., Lefcoe N.M., Johansson S.A. Influence of Dosing Frequency and Schedule on the Response of Chronic Asthmatics to the Aerosol Steroid. Budesonide. J. Allergy Clin. Immunol. 1982; 70(4)288–298
   PubMed Web of Science ®Google Scholar
• Miller-Larsson A., Mattsson H., Hjertberg E., Dahlbäck M., Tunek A., Brattsand R. Reversible Fatty Acid Conjugation of Budesonide: Novel Mechanism for Prolonged Retention of Topically Applied Steroid in Airway Tissue. Drug Metab. Dispos. 1998; 26(7)623–630
   PubMed Web of Science ®Google Scholar
• Wieslander E., Delander E.-L., Jarkelid L., Hjertberg E., Tunek A., Brattsand R. Pharmacologic Importance of the Reversible Fatty Acid Conjugation of Budesonide Studied in a Rat Cell Line in vitro. Am. J. Respir. Cell. Mol. Biol. 1998; 19(3)477–484
   PubMed Web of Science ®Google Scholar
• Thorsson L., Thunnisen F.B., Korn S., Carlshaf A., Edsbäcker S., Wouters E.F. Formation of Fatty Acid Conjugates of Budesonide in Human Lung Tissue in vivo. Am. J. Respir. Crit. Care Med. 1998; 157(3)A404
   Google Scholar
• Miller-Larsson A., Jansson P., Runström A., Brattsand R. Prolonged Airway Activity and Improved Selectivity of Budesonide Possibly Due to Esterification. Am. J. Respir. Crit. Care Med. 2000; 162(suppl: 4 part 1)1455–1461
   PubMed Web of Science ®Google Scholar
• Horn C.R., Clark T.J.H., Cochrane G.M. Compliance with Inhaled Therapy and Morbidity from Asthma. Respir. Med. 1990; 84(1)67–70
   PubMed Web of Science ®Google Scholar
• Mann M., Eliasson O., Patel K., ZuWallack R.L. A Comparison of the Effects of bid and qid Dosing on Compliance with Inhaled Flunisolide. Chest 1992; 101(2)496–499
   PubMed Web of Science ®Google Scholar
• Jordan T.J., Reichman L.B. Once-Daily Versus Twice-Daily Dosing of Theophylline. A Decision Analysis Approach to Evaluating Theophylline Blood Levels and Compliance. Am. Rev. Respir. Dis. 1989; 140(6)1573–1577
   PubMedGoogle Scholar